Maintenance of the Gag/Gag-Pol Ratio Is Important for Human Immunodeficiency Virus Type 1 RNA Dimerization and Viral Infectivity

ABSTRACT Production of the human immunodeficiency virus type 1 (HIV-1) Gag-Pol precursor protein results from a −1 ribosomal frameshifting event. In infected cells, this generates Gag and Gag-Pol in a ratio that is estimated to be 20:1, a ratio that is conserved among retroviruses. To examine the impact of this ratio on HIV-1 replication and viral assembly, we altered the Gag/Gag-Pol ratio in virus-producing cells by cotransfecting HIV-1 proviral DNA with an HIV-1 Gag-Pol expression vector. Two versions of the Gag-Pol expression vector were used; one contains an active protease [PR(+)], and the other contains an inactive protease [PR(−)]. In an attempt to produce viral particles with Gag/Gag-Pol ratios ranging from 20:21 to 20:1 (wild type), 293T cells were cotransfected with various ratios of wild-type proviral DNA and proviral DNA from either Gag-Pol expression vector. Viral particles derived from cells with altered Gag/Gag-Pol ratios via overexpression of PR(−) Gag-Pol showed a ratio-dependent defect in their virion protein profiles. However, the defects in virion infectivity were independent of the nature of the Gag-Pol expression vector, i.e., PR(+) or PR(−). Based on equivalent input of reverse transcriptase activity, we estimated that HIV-1 infectivity was reduced 250- to 1,000-fold when the Gag/Gag-Pol ratio in the virion-producing cells was altered from 20:1 to 20:21. Although virion RNA packaging was not affected by altering Gag/Gag-Pol ratios, changing the ratio from 20:1 to 20:21 progressively reduced virion RNA dimer stability. The impact of the Gag/Gag-Pol ratio on virion RNA dimerization was amplified when the Gag-Pol PR(−) expression vector was expressed in virion-producing cells. Virions produced from cells expressing Gag and Gag-Pol PR(−) in a 20:21 ratio contained mainly monomeric RNA. Our observations provide the first direct evidence that, in addition to proteolytic processing, the ratio of Gag/Gag-Pol proteins is also important for RNA dimerization and that stable RNA dimers are not required for encapsidation of genomic RNA in HIV-1.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  Tina M. Cairns,et al.  RNA Dimerization Defect in a Rous Sarcoma Virus Matrix Mutant , 2000, Journal of Virology.

[3]  M. Linial.  Foamy Viruses Are Unconventional Retroviruses , 1999, Journal of Virology.

[4]  M. Churchill,et al.  Diminished Production of Human Immunodeficiency Virus Type 1 in Astrocytes Results from Inefficient Translation ofgag, env, and nef mRNAs despite Efficient Expression of Tat and Rev , 1999, Journal of Virology.

[5]  M. Wainberg,et al.  Cotransfection of mutated forms of human immunodeficiency virus type 1 Gag-Pol with wild-type constructs can interfere with processing and viral replication. , 1998, Journal of human virology.

[6]  J. Kappes,et al.  Functional RT and IN incorporated into HIV‐1 particles independently of the Gag/Pol precursor protein , 1997, The EMBO journal.

[7]  M. Wainberg,et al.  Effects of mutations in Pr160gag-pol upon tRNA(Lys3) and Pr160gag-plo incorporation into HIV-1. , 1997, Journal of molecular biology.

[8]  C. Craik,et al.  Intracellular expression of human immunodeficiency virus type 1 (HIV-1) protease variants inhibits replication of wild-type and protease inhibitor-resistant HIV-1 strains in human T-cell lines , 1996, Journal of virology.

[9]  B. Berkhout,et al.  Role of the DIS hairpin in replication of human immunodeficiency virus type 1 , 1996, Journal of virology.

[10]  A. Lever,et al.  trans-acting proteins involved in RNA encapsidation and viral assembly in human immunodeficiency virus type 1 , 1996, Journal of virology.

[11]  L. Babe,et al.  Trans-dominant inhibitory human immunodeficiency virus type 1 protease monomers prevent protease activation and virion maturation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Wainberg,et al.  Incorporation of excess wild-type and mutant tRNA(3Lys) into human immunodeficiency virus type 1 , 1994, Journal of virology.

[13]  M Laughrea,et al.  A 19-nucleotide sequence upstream of the 5' major splice donor is part of the dimerization domain of human immunodeficiency virus 1 genomic RNA. , 1994, Biochemistry.

[14]  S. Kent,et al.  HIV Infection of monocyte‐derived macrophages in vitro reduces phagocytosis of Candida albicans , 1994, Journal of leukocyte biology.

[15]  W. Fu,et al.  Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions , 1994, Journal of virology.

[16]  J. Darlix,et al.  Analytical study of rat retrotransposon VL30 RNA dimerization in vitro and packaging in murine leukemia virus. , 1994, Journal of molecular biology.

[17]  C. Ehresmann,et al.  Identification of the primary site of the human immunodeficiency virus type 1 RNA dimerization in vitro. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Wainberg,et al.  Role of Pr160gag-pol in mediating the selective incorporation of tRNA(Lys) into human immunodeficiency virus type 1 particles , 1994, Journal of virology.

[19]  C. Ehresmann,et al.  Dimerization of human immunodeficiency virus type 1 RNA involves sequences located upstream of the splice donor site. , 1994, Nucleic acids research.

[20]  W. Fu,et al.  Maturation of dimeric viral RNA of Moloney murine leukemia virus , 1993, Journal of virology.

[21]  K. Nagashima,et al.  Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles. , 1993, Virology.

[22]  C. Gabus,et al.  Analytical study of avian reticuloendotheliosis virus dimeric RNA generated in vivo and in vitro , 1992, Journal of virology.

[23]  S. Goff,et al.  Mutational analysis of the gag-pol junction of Moloney murine leukemia virus: requirements for expression of the gag-pol fusion protein , 1992, Journal of virology.

[24]  C. Morrow,et al.  The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles , 1992, Journal of virology.

[25]  C. Morrow,et al.  Overexpression of the gag-pol precursor from human immunodeficiency virus type 1 proviral genomes results in efficient proteolytic processing in the absence of virion production , 1991, Journal of virology.

[26]  R C Craven,et al.  Form, function, and use of retroviral gag proteins. , 1991, AIDS.

[27]  F. Barré-Sinoussi,et al.  Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1. , 1990, Journal of molecular biology.

[28]  A. Smith,et al.  Human immunodeficiency virus type 1 Pr55gag and Pr160gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into viruslike particles , 1990, Journal of virology.

[29]  C. Gabus,et al.  cis elements and trans-acting factors involved in dimer formation of murine leukemia virus RNA , 1990, Journal of virology.

[30]  J. Sodroski,et al.  Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Sodroski,et al.  Functional role of human immunodeficiency virus type 1 vpu. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[32]  D. Hatfield,et al.  Suppression of UAA and UGA termination codons in mutant murine leukemia viruses , 1989, Journal of virology.

[33]  D. Hatfield,et al.  Translational readthrough of the murine leukemia virus gag gene amber codon does not require virus-induced alteration of tRNA , 1989, Journal of virology.

[34]  H. Varmus,et al.  Signals for ribosomal frameshifting in the rous sarcoma virus gag-pol region , 1988, Cell.

[35]  A. Panganiban.  Retroviral gag gene amber codon suppression is caused by an intrinsic cis-acting component of the viral mRNA , 1988, Journal of virology.

[36]  S. Goff,et al.  Expression of the gag-pol fusion protein of Moloney murine leukemia virus without gag protein does not induce virion formation or proteolytic processing , 1988, Journal of virology.

[37]  H. Varmus,et al.  Characterization of ribosomal frameshifting in HIV-1 gag-pol expression , 1988, Nature.

[38]  T. Yasunaga,et al.  Inhibition of retroviral protease activity by an aspartyl proteinase inhibitor , 1987, Nature.

[39]  H. Varmus,et al.  Two efficient ribosomal frameshifting events are required for synthesis of mouse mammary tumor virus gag-related polyproteins. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[40]  H. Varmus,et al.  Expression of the Rous sarcoma virus pol gene by ribosomal frameshifting. , 1985, Science.

[41]  M. Shibuya,et al.  Murine leukemia virus maturation: protease region required for conversion from "immature" to "mature" core form and for virus infectivity. , 1985, Virology.

[42]  D. Baltimore,et al.  Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase , 1981, Journal of virology.

[43]  S. Goff,et al.  RNA packaging. , 1996, Current topics in microbiology and immunology.

[44]  K. Mergener,et al.  Analysis of HIV particle formation using transient expression of subviral constructs in mammalian cells. , 1992, Virology.

[45]  W. S. Hayward,et al.  Retroviral gene expression. , 1981, Current topics in microbiology and immunology.